Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating patients with metastatic liver cancer that cannot be removed by surgery.
Epistemonikos ID: 80e09d35e039d83e4b8f31c6a8b4dadf0faccb7f
First added on: May 04, 2024